Could an Imaging Test Predict How Well You’ll Respond to a Stem Cell Transplant?

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated November 4th, 2020

Could an Imaging Test Predict How Well You’ll Respond to a Stem Cell Transplant?

×
NOW
PLAYING
27-Year-Old's Bad Back Turned Out To Be Cancer, Family Says An Accurate Diagnosis Was Delayed By COVID-19
NOW
PLAYING
5 COVID-19 Vaccine Questions Answered by Expert Physician
NOW
PLAYING
COVID-19 Vaccine Recommended for Everyone with Cancer
NOW
PLAYING
Everyone Is Talking About Monoclonal Antibodies as Treatment For Reducing Risk of Symptomatic COVID — Is It an Option for Those With Cancer?
NOW
PLAYING
Cancer Screenings Dropped By More Than 75% at Start of Pandemic — Don't Delay Yours
NOW
PLAYING
ABC's Remarkably Brave Robin Roberts Looks Towards A Brighter Future Nine Years After Bone Marrow Transplant: "This Too Shall Pass"

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.